The Effect of Mandala Coloring Activity on Stress and Anxiety in Mothers with Babies in NICU
Launched by ISTANBUL MEDENIYET UNIVERSITY · Jul 5, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how coloring mandalas—intricate patterns that can be colored in—can help reduce stress and anxiety for mothers who have babies in the neonatal intensive care unit (NICU). The study aims to see if this creative activity can provide emotional support to moms during a challenging time, as having a baby in the NICU can be very stressful.
To participate, mothers need to meet certain criteria. They must have a baby in the NICU for at least three days, be at least 18 years old, and be able to paint without any physical limitations. It's important that they do not have any mental health issues or communication difficulties. Participants will be invited to engage in mandala coloring, which may help them feel more relaxed and less anxious while they support their baby. This trial is currently recruiting mothers who meet these guidelines, and it offers a unique opportunity to combine art with emotional well-being during a tough period.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Mothers whose baby has been in the neonatal intensive care unit for at least 3 days and staying in the mother's hotel,
- • Having agreed to participate in the research/approved the informed consent form
- • No visual or hearing impairment
- • Being over 18 years old,
- • Being at least literate
- • The absence of any problem that would prevent him/her from painting mandala (no problem in his arm or hand that would prevent his movement)
- • Must not have a diagnosis of mental illness/anxiety disorder
- Exclusion Criteria:
- • Mothers with communication and perception problems will not be included in the study.
- • Mothers with comprehension and speech problems will not be included in the study.
- • Mothers with psychiatric illness and taking medication will not be included in the study.
About Istanbul Medeniyet University
Istanbul Medeniyet University is a prominent academic institution based in Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to conduct innovative studies aimed at improving healthcare outcomes. With a strong emphasis on ethical standards and scientific rigor, Istanbul Medeniyet University collaborates with healthcare professionals and researchers to explore new therapeutic strategies and contribute to the global body of medical knowledge. Their commitment to fostering a research-driven environment facilitates the development of cutting-edge treatments and enhances patient care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Kadıköy, Turkey
Istanbul, , Turkey
Patients applied
Trial Officials
Aynur Aytekin Özdemir, PhD
Study Director
Istanbul Medeniyet University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported